InterCure Ltd. (INCR)
NASDAQ: INCR · IEX Real-Time Price · USD
2.300
+0.020 (0.88%)
At close: Jul 19, 2024, 4:00 PM
2.390
+0.090 (3.91%)
Pre-market: Jul 22, 2024, 7:20 AM EDT
InterCure Market Cap
InterCure has a market cap or net worth of $104.82 million as of July 22, 2024. Its market cap has increased by 40.32% in one year.
Market Cap
104.82M
Enterprise Value
126.86M
1-Year Change
40.32%
Ranking
Category
Stock Price
$2.30
Market Cap Chart
Since September 1, 2021, InterCure's market cap has decreased from $288.40M to $104.82M, a decrease of -63.66%. That is a compound annual growth rate of -29.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 104.80M | 78.23% |
| Dec 29, 2023 | 58.80M | -60.51% |
| Dec 30, 2022 | 148.90M | -46.23% |
| Dec 31, 2021 | 276.90M | -3.99% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BrainsWay | 108.34M |
| Regulus Therapeutics | 108.02M |
| CytomX Therapeutics | 107.53M |
| Zentek | 106.80M |
| Coya Therapeutics | 106.55M |
| FibroGen | 104.45M |
| IO Biotech | 104.09M |
| Eledon Pharmaceuticals | 103.97M |